Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

This publication has 16 references indexed in Scilit:

• Randomized Comparison of DAT Versus ADE as Induction Chemotherapy in Children and Younger Adults With Acute Myeloid Leukemia. Results of the Medical Research Council's 10th AML Trial (MRC AML10)
  Blood, 1997
• Dose intensification in acute myloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's ATML9 study
  British Journal of Haematology, 1996
• Autologous Bone Marrow Transplantation versus Intensive Consolidation Chemotherapy for Acute Myeloid Leukemia in Childhood
  New England Journal of Medicine, 1996
• A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]
  Blood, 1996
• Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia
  New England Journal of Medicine, 1995
• Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
  New England Journal of Medicine, 1994
• Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial
  British Journal of Haematology, 1989
• Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up
  Blood, 1988
• TRANSPLANTATION OF UNPURGED AUTOLOGOUS BONE-MARROW IN ACUTE MYELOID LEUKAEMIA IN FIRST REMISSION
  The Lancet, 1984
• Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
  New England Journal of Medicine, 1983